{"id":330064,"date":"2026-10-28T11:41:39","date_gmt":"2026-10-28T06:11:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=330064"},"modified":"2026-10-28T11:41:39","modified_gmt":"2026-10-28T06:11:39","slug":"why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/","title":{"rendered":"Astrazeneca Pharma India Ltd. (ASTRAZEN): AstraZeneca Pharma Share Price Rises 5.11% to Rs 6,383.70 Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN)<\/a> share price rose to Rs 6,383.7 today, up 5.11% from the previous close. Market cap was Rs 15,182.75 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">AstraZeneca Pharma share price stands at Rs 6,383.70 as of 28 October 2026 at 11:37 AM IST, up Rs 310.60 or 5.11% from the previous close of Rs 6,073.10. The pharmaceutical company carries a market capitalisation of Rs 15,182.75 crore, and the AstraZeneca Pharma share price rise is the event this update examines.<\/p>\n<p>Univest figures confirm the price action, but they do not point to a specific company trigger. The AstraZeneca Pharma stock is gaining today on price action alone, so this report stays with what the latest Univest figures show: the day&#8217;s range, valuation multiples, capital returns, the industry benchmark and listed peers.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#AstraZeneca_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"AstraZeneca Pharma Share Price Today: Price Action Analysis\">AstraZeneca Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\" title=\"Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis\">Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Why_Investors_Are_Watching_AstraZeneca_Pharma\" title=\"Why Investors Are Watching AstraZeneca Pharma\">Why Investors Are Watching AstraZeneca Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#About_AstraZeneca_Pharma\" title=\"About AstraZeneca Pharma\">About AstraZeneca Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Why_is_AstraZeneca_Pharma_share_price_rising_today\" title=\"Why is AstraZeneca Pharma share price rising today?\">Why is AstraZeneca Pharma share price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#What_is_the_AstraZeneca_Pharma_share_price_today\" title=\"What is the AstraZeneca Pharma share price today?\">What is the AstraZeneca Pharma share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#What_is_the_market_capitalisation_of_AstraZeneca_Pharma\" title=\"What is the market capitalisation of AstraZeneca Pharma?\">What is the market capitalisation of AstraZeneca Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#What_is_the_PE_ratio_of_AstraZeneca_Pharma\" title=\"What is the P\/E ratio of AstraZeneca Pharma?\">What is the P\/E ratio of AstraZeneca Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#What_is_the_ROCE_of_AstraZeneca_Pharma\" title=\"What is the ROCE of AstraZeneca Pharma?\">What is the ROCE of AstraZeneca Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#What_are_the_EPS_and_book_value_of_AstraZeneca_Pharma\" title=\"What are the EPS and book value of AstraZeneca Pharma?\">What are the EPS and book value of AstraZeneca Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Does_AstraZeneca_Pharma_pay_a_dividend\" title=\"Does AstraZeneca Pharma pay a dividend?\">Does AstraZeneca Pharma pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#How_does_AstraZeneca_Pharma_compare_with_pharmaceutical_peers\" title=\"How does AstraZeneca Pharma compare with pharmaceutical peers?\">How does AstraZeneca Pharma compare with pharmaceutical peers?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-rise-today-2026\/#Track_AstraZeneca_Pharma_Share_Price_on_Univest\" title=\"Track AstraZeneca Pharma Share Price on Univest\">Track AstraZeneca Pharma Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"AstraZeneca_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>AstraZeneca Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,383.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,073.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 310.6 (+5.11%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,058.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,383.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,058.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,182.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>For readers following the AstraZeneca Pharma share price today, the points to monitor next are how the stock holds against its day high of Rs 6,383.70, how its P\/E ratio of 89.51 compares with the industry median of 30.74, and how its ROCE of 31.24% stacks up against pharmaceutical peers.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) rose to Rs 6,383.7 from the previous close of Rs 6,073.1, a move of Rs 310.6 or 5.11%. The stock opened at Rs 6,058.5, reached a high of Rs 6,383.7, recorded a low of Rs 6,058.5.<\/p>\n<p>AstraZeneca Pharma share price traded at Rs 6,383.70, a gain of Rs 310.60 or 5.11% over the previous close of Rs 6,073.10. The stock opened at Rs 6,058.50, below that previous close, and has moved between Rs 6,058.50 and Rs 6,383.70 so far today.<\/p>\n<p>The day low of Rs 6,058.50 is below the previous close of Rs 6,073.10, so the stock dipped under its prior reference level at one point today. That low equals the opening price, so the stock has not traded below its open so far today. The last traded price of Rs 6,383.70 is the day high, and it is Rs 325.20 above the opening level. The AstraZeneca Pharma share price update therefore shows a gain of 5.11% on the previous close.<\/p>\n<p>With the price move laid out, the next question is what the company&#8217;s reported fundamentals add to the picture of AstraZeneca Pharma stock performance.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,182.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">89.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 361.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.59%<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P\/E 89.51x, P\/B 16.79x, ROE 23.02%, ROCE 31.24%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 15,182.75 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 89.51x, P\/B at 16.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.59%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">89.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">43.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.21x to 577.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.71x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,182.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 696.43 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 89.51x, which is above the benchmark median of 30.74x, a difference of +191.18%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.23%, a difference of +104.99%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.17%, a difference of +137.21%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,18,204.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,40,780<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,73,828.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">82.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,520.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,304.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">105.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 89.51x compared with the displayed peer median of 82.48x. The comparison is relative and should not be read as a recommendation. Its ROE of 23.02% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 15,182.75 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_AstraZeneca_Pharma\"><\/span><strong>Why Investors Are Watching AstraZeneca Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking AstraZeneca Pharma can follow the price move, the valuation and capital-return figures and the sector benchmark. Each point below rests on figures from the latest Univest data and none implies a recommendation or a forecast.<\/p>\n<ul>\n<li>Price action: the stock is up 5.11% at Rs 6,383.70, with a day range of Rs 6,058.50 to Rs 6,383.70.<\/li>\n<li>Capital returns: ROCE of 31.24% is above the Healthcare benchmark median of 13.17%.<\/li>\n<li>Valuation: P\/E of 89.51 is above the industry median of 30.74, and P\/B of 16.79 is above the median of 2.71.<\/li>\n<li>Per-share figures: EPS of Rs 67.85 and book value of Rs 361.68 per share frame the valuation multiples.<\/li>\n<li>Size: market capitalisation of Rs 15,182.75 crore compares with an industry median of Rs 696.43 crore.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_AstraZeneca_Pharma\"><\/span><strong>About AstraZeneca Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astrazeneca Pharma India Ltd. is a listed company operating in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry, according to latest Univest data. Within its same-industry benchmark group of 199 companies, it has a market capitalisation of Rs 15,182.75 crore, EPS of Rs 67.85 and a book value of Rs 361.68 per share.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_AstraZeneca_Pharma_share_price_rising_today\"><\/span><strong>Why is AstraZeneca Pharma share price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Univest figures confirm the price action, but they do not point to a specific company trigger. The stock traded at Rs 6,383.70, up 5.11% from the previous close of Rs 6,073.10, as of 28 October 2026 at 11:37 AM IST.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_AstraZeneca_Pharma_share_price_today\"><\/span><strong>What is the AstraZeneca Pharma share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The AstraZeneca Pharma share price was Rs 6,383.70 at 11:37 AM IST on 28 October 2026. That is a rise of Rs 310.60, or 5.11%, from the previous close of Rs 6,073.10, after an opening price of Rs 6,058.50.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_AstraZeneca_Pharma\"><\/span><strong>What is the market capitalisation of AstraZeneca Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> AstraZeneca Pharma has a market capitalisation of Rs 15,182.75 crore. That is above the Pharmaceuticals &amp; Drugs industry benchmark median of Rs 696.43 crore and above the benchmark average of Rs 13,492.66 crore across 199 companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_AstraZeneca_Pharma\"><\/span><strong>What is the P\/E ratio of AstraZeneca Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The AstraZeneca Pharma P\/E ratio is 89.51. The Pharmaceuticals &amp; Drugs industry benchmark has a median P\/E of 30.74 and an average of 43.30, so the company sits above the median and above the average.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_ROCE_of_AstraZeneca_Pharma\"><\/span><strong>What is the ROCE of AstraZeneca Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> AstraZeneca Pharma has a ROCE of 31.24%, which measures returns generated on capital employed. The industry benchmark median ROCE is 13.17% and the average is 12.81%, so the company figure is above the median and above the average.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_EPS_and_book_value_of_AstraZeneca_Pharma\"><\/span><strong>What are the EPS and book value of AstraZeneca Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> AstraZeneca Pharma has an EPS of Rs 67.85, showing earnings attributable to each share, and a book value of Rs 361.68 per share. The P\/B ratio is 16.79, against an industry median of 2.71.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_AstraZeneca_Pharma_pay_a_dividend\"><\/span><strong>Does AstraZeneca Pharma pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest Univest data shows a dividend yield of 0.59% for AstraZeneca Pharma. Dividend yield describes the historical or current payout relative to the share price and is not a guarantee of any future payout.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_AstraZeneca_Pharma_compare_with_pharmaceutical_peers\"><\/span><strong>How does AstraZeneca Pharma compare with pharmaceutical peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The AstraZeneca Pharma P\/E of 89.51 is lower than 1 of 5 listed peers and higher than 4. Its ROCE of 31.24% is higher than 5 of 5 listed peers, and its market capitalisation is smaller than each peer.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is AstraZeneca Pharma share price rising today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Univest figures confirm the price action, but they do not point to a specific company trigger. The stock traded at Rs 6,383.70, up 5.11% from the previous close of Rs 6,073.10, as of 28 October 2026 at 11:37 AM IST.\"}},{\"@type\":\"Question\",\"name\":\"What is the AstraZeneca Pharma share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The AstraZeneca Pharma share price was Rs 6,383.70 at 11:37 AM IST on 28 October 2026. That is a rise of Rs 310.60, or 5.11%, from the previous close of Rs 6,073.10, after an opening price of Rs 6,058.50.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of AstraZeneca Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"AstraZeneca Pharma has a market capitalisation of Rs 15,182.75 crore. That is above the Pharmaceuticals & Drugs industry benchmark median of Rs 696.43 crore and above the benchmark average of Rs 13,492.66 crore across 199 companies.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of AstraZeneca Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The AstraZeneca Pharma P\/E ratio is 89.51. The Pharmaceuticals & Drugs industry benchmark has a median P\/E of 30.74 and an average of 43.30, so the company sits above the median and above the average.\"}},{\"@type\":\"Question\",\"name\":\"What is the ROCE of AstraZeneca Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"AstraZeneca Pharma has a ROCE of 31.24%, which measures returns generated on capital employed. The industry benchmark median ROCE is 13.17% and the average is 12.81%, so the company figure is above the median and above the average.\"}},{\"@type\":\"Question\",\"name\":\"What are the EPS and book value of AstraZeneca Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"AstraZeneca Pharma has an EPS of Rs 67.85, showing earnings attributable to each share, and a book value of Rs 361.68 per share. The P\/B ratio is 16.79, against an industry median of 2.71.\"}},{\"@type\":\"Question\",\"name\":\"Does AstraZeneca Pharma pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest Univest data shows a dividend yield of 0.59% for AstraZeneca Pharma. Dividend yield describes the historical or current payout relative to the share price and is not a guarantee of any future payout.\"}},{\"@type\":\"Question\",\"name\":\"How does AstraZeneca Pharma compare with pharmaceutical peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The AstraZeneca Pharma P\/E of 89.51 is lower than 1 of 5 listed peers and higher than 4. Its ROCE of 31.24% is higher than 5 of 5 listed peers, and its market capitalisation is smaller than each peer.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_AstraZeneca_Pharma_Share_Price_on_Univest\"><\/span><strong>Track AstraZeneca Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Users can track the live AstraZeneca Pharma share price on Univest, along with fundamental ratios such as P\/E, P\/B and ROCE, 52-week levels and wider market insights. The AstraZeneca Pharma share price today of Rs 6,383.70 and the 5.11% rise are part of a market update, not a recommendation, and the figures here will move as the day&#8217;s trade continues.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrazeneca Pharma India Ltd. Share Price rises to Rs 6,383.7, marking a 5.11% rise today. Market cap stands at Rs 15,182.75 crore.<\/p>\n","protected":false},"author":35,"featured_media":330063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-330064","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["330063"],"rank_math_title":["AstraZeneca Pharma Share Price Rises 5.11%: Price Analysis"],"rank_math_description":["AstraZeneca Pharma share price rose 5.11% to Rs 6,383.70 today. See price action, fundamental analysis, sector benchmark and peer comparison in one place."],"rank_math_focus_keyword":["AstraZeneca Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Astrazeneca_Pharma_India_Ltd_ASTRAZEN_AstraZeneca_Pharma_Share_Price_Rises_511_to_Rs_638370_Today_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/330064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=330064"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/330064\/revisions"}],"predecessor-version":[{"id":330065,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/330064\/revisions\/330065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/330063"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=330064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=330064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=330064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}